Resmetirom 瑞司美替罗60mg
Resmetirom 瑞司美替罗80mg
Resmetirom 瑞司美替罗100mg

Resmetirom

Another Name
Resmetirom TERN-201 TERN-101,瑞美替罗,瑞司美替罗
Indications
Nonalcoholic steatohepatitis (NASH)
Reg No
09 L 1195/24 09 L 1192/24 09 L 1196/24
Inspection No
2129-24 2130-24 2126-24
dosage form:Pills
Specs:60mg/ 80mg/ 100mg* 30 Pills
Indate:24 months
Date：2024-10-19 Views：1426
Drug Info

COMPOSITION:

  • Each film-coated tablet contains Resmetirom……………………………………60mg.
  • Each film-coated tablet contains Resmetirom……………………………………80mg.
  • Each film-coated tablet contains Resmetirom……………………………………100mg.

INDICATION:

LuciRes is a thyroid hormone receptor-beta (THR-beta) agonist indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis).

DOSAGE AND USE:

• The recommended dosage of LuciRes is based on actual body weight. For patients weighing:

<100 kg, the recommended dosage is 80 mg orally once daily.

⩾ 100 kg, the recommended dosage is 100 mg orally once daily.

• Administer LuciRes with or without food.

STORAGE:

In a dry place and store at 20℃ to 25℃.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciRes during Pregnancy and Lactation.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/resmetirom/

Related News